Table 2: Detection of Chlamydia from genital and extra genital sites of the female and male partners in clinical specimens obtained in 2012.
| Clinical samples |
Identification of ะก. trachomatis by PCR |
| Female partner |
Male partner |
| AmpiSens- Eph |
AmpiSens- FL |
PCR-nvCT a)
|
PCR-orf8
|
PCR-orf2
|
Genovarb)
|
AmpiSens- Eph |
AmpiSens- FL |
PCR-nvCT a)
|
PCR-orf8
|
PCR-orf2
|
Genovarb)
|
| Conjunctiva |
- |
- |
+ |
+ |
- |
E |
- |
- |
+ |
+ |
- |
E |
| Oropharynx |
- |
- |
+ |
+ |
- |
E |
- |
- |
+ |
- |
- |
E |
| Urethra & Cervix |
- |
- |
+ |
- |
- |
E |
- |
- |
+ |
+ |
- |
E |
| Blood |
- |
- |
+ |
- |
- |
E |
- |
- |
+ |
- |
- |
E |
a) Presence of 377 bp deletion in orf1 of the cryptic plasmid; b)C. trachomatis genovar was determined by sequencing of the VD2 region of the ompA gene.